Medicamen Biotech: Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30 of the SEBI (Listing Obligatons and Disclosure Requirements) Regulations 2025 the Company hereby informs that Mr. Harish Pande and Mr. Arun Kumar have completed their term as an Independent Directors of the Company.